These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 25026539)

  • 21. Treating chemotherapy-induced peripheral neuropathy.
    Das M
    Lancet Oncol; 2017 Apr; 18(4):e202. PubMed ID: 28285841
    [No Abstract]   [Full Text] [Related]  

  • 22. Chemotherapy-Induced Peripheral Neuropathy.
    Tzatha E; DeAngelis LM
    Oncology (Williston Park); 2016 Mar; 30(3):240-4. PubMed ID: 26984218
    [No Abstract]   [Full Text] [Related]  

  • 23. [Chemotherapy-induced peripheral neuropathy].
    Noguchi E; Maeda Y
    Gan To Kagaku Ryoho; 2011 Nov; 38(11):1773-6. PubMed ID: 22083183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple myeloma: a multifactorial problem for the hand surgeon as a patient.
    Al-Qattan MM
    J Hand Surg Eur Vol; 2007 Feb; 32(1):110-1. PubMed ID: 17097782
    [No Abstract]   [Full Text] [Related]  

  • 25. Isoniazid induced peripheral neuropathy.
    Mahashur AA
    J Assoc Physicians India; 1992 Oct; 40(10):651-2. PubMed ID: 1344033
    [No Abstract]   [Full Text] [Related]  

  • 26. Chemotherapy-induced peripheral neuropathy.
    Armstrong T; Almadrones L; Gilbert MR
    Oncol Nurs Forum; 2005 Mar; 32(2):305-11. PubMed ID: 15759068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient-reported peripheral neuropathy of doxorubicin and cisplatin with and without paclitaxel in the treatment of advanced endometrial cancer: Results from GOG 184.
    Cella D; Huang H; Homesley HD; Montag A; Salani R; De Geest K; Lee R; Spirtos NM
    Gynecol Oncol; 2010 Dec; 119(3):538-42. PubMed ID: 20863554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A case of peripheral neuropathy due to the use of kefzol].
    Vlasiuk VN; Medynskiĭ GM
    Vrach Delo; 1990 May; (5):82-3. PubMed ID: 2168604
    [No Abstract]   [Full Text] [Related]  

  • 29. Negative-balance isolated pelvic perfusion in patients with incurable symptomatic rectal cancer: results and drug dose correlation to adverse events.
    Murata S; Onozawa S; Kim C; Tajima H; Kimata R; Uchida E; Kumita S
    Acta Radiol; 2014 Sep; 55(7):793-801. PubMed ID: 24097815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peripheral neuropathy induced by oxaliplatin-based chemotherapy.
    J Support Oncol; 2006 Feb; 4(2):82-3. PubMed ID: 16499128
    [No Abstract]   [Full Text] [Related]  

  • 31. CI-PERINOMS: chemotherapy-induced peripheral neuropathy outcome measures study.
    CI-PERINOMS Study Group
    J Peripher Nerv Syst; 2009 Jun; 14(2):69-71. PubMed ID: 19691527
    [No Abstract]   [Full Text] [Related]  

  • 32. Strategies to manage chemotherapy-induced peripheral neuropathy.
    Sharma MR
    Clin Adv Hematol Oncol; 2017 Dec; 15(12):938-940. PubMed ID: 29315285
    [No Abstract]   [Full Text] [Related]  

  • 33. Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy.
    Hausheer FH; Schilsky RL; Bain S; Berghorn EJ; Lieberman F
    Semin Oncol; 2006 Feb; 33(1):15-49. PubMed ID: 16473643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemotherapy-induced peripheral neuropathy: a review and implications for oncology nursing practice.
    Wickham R
    Clin J Oncol Nurs; 2007 Jun; 11(3):361-76. PubMed ID: 17623621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: the Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study.
    Pignata S; De Placido S; Biamonte R; Scambia G; Di Vagno G; Colucci G; Febbraro A; Marinaccio M; Lombardi AV; Manzione L; Cartenì G; Nardi M; Danese S; Valerio MR; de Matteis A; Massidda B; Gasparini G; Di Maio M; Pisano C; Perrone F
    BMC Cancer; 2006 Jan; 6():5. PubMed ID: 16398939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitamin E levels during chemotherapy for ovarian carcinoma.
    Ananth N; Shetty BV; Vasudevan DM
    Natl Med J India; 2003; 16(4):231-2. PubMed ID: 14606777
    [No Abstract]   [Full Text] [Related]  

  • 37. [A new approach to prevent the chemotherapy-induced peripheral neuropathy].
    Kawashiri T
    Nihon Yakurigaku Zasshi; 2019; 153(4):200. PubMed ID: 30971662
    [No Abstract]   [Full Text] [Related]  

  • 38. Calcium channel blockers reduce oxaliplatin-induced acute neuropathy: a retrospective study of 69 male patients receiving modified FOLFOX6 therapy.
    Tatsushima Y; Egashira N; Narishige Y; Fukui S; Kawashiri T; Yamauchi Y; Oishi R
    Biomed Pharmacother; 2013 Feb; 67(1):39-42. PubMed ID: 23206755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overcoming peripheral neuropathy.
    Boucaud-Obali D
    Body Posit; 2002; 15(4):27-9. PubMed ID: 12400478
    [No Abstract]   [Full Text] [Related]  

  • 40. Risk of docetaxel-induced peripheral neuropathy among 1,725 Danish patients with early stage breast cancer.
    Eckhoff L; Knoop AS; Jensen MB; Ejlertsen B; Ewertz M
    Breast Cancer Res Treat; 2013 Nov; 142(1):109-18. PubMed ID: 24132874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.